tiprankstipranks
Trending News
More News >
Neuland Laboratories Ltd. (IN:NEULANDLAB)
:NEULANDLAB
India Market
Advertisement

Neuland Laboratories Ltd. (NEULANDLAB) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

NEULANDLAB Analyst Ratings

Moderate Buy
1Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Neuland
Laboratories Ltd.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NEULANDLAB Stock 12 Month Forecast

Average Price Target

₹15,200.00
▲(28.05%Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Neuland Laboratories Ltd. in the last 3 months. The average price target is ₹15,200.00 with a high forecast of ₹15,200.00 and a low forecast of ₹15,200.00. The average price target represents a 28.05% change from the last price of ₹11,870.35.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6023":"₹6,023","16648":"₹16,648","8679.25":"₹8,679.3","11335.5":"₹11,335.5","13991.75":"₹13,991.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15200,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹15K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15200,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹15K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15200,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹15K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6023,8679.25,11335.5,13991.75,16648],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Jan<br/>2025","12":"Apr<br/>2025","25":"Apr<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11464,11751.384615384615,12038.76923076923,12326.153846153846,12613.538461538461,12900.923076923076,13188.307692307691,13475.692307692309,13763.076923076922,14050.461538461539,14337.846153846152,14625.23076923077,14912.615384615385,{"y":15200,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11464,11751.384615384615,12038.76923076923,12326.153846153846,12613.538461538461,12900.923076923076,13188.307692307691,13475.692307692309,13763.076923076922,14050.461538461539,14337.846153846152,14625.23076923077,14912.615384615385,{"y":15200,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11464,11751.384615384615,12038.76923076923,12326.153846153846,12613.538461538461,12900.923076923076,13188.307692307691,13475.692307692309,13763.076923076922,14050.461538461539,14337.846153846152,14625.23076923077,14912.615384615385,{"y":15200,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6251.14,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":7581.33,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6024.77,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":7705.26,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":9365.34,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":12493.05,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":12520.58,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14609.65,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":16647.36,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14297,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14297,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10608.36,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11464,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target₹15,200Average Price Target₹15,200Lowest Price Target₹15,200
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on IN:NEULANDLAB
TipRanks AITipRanks
Not Ranked
TipRanks
₹15,988
Hold
34.69%
Upside
Reiterated
07/15/25
Neuland Laboratories' overall stock score reflects strong financial performance and positive technical indicators, tempered by high valuation concerns. The company's robust revenue growth and solid balance sheet position it well for future growth, but the high P/E ratio and overbought technical signals suggest caution in valuation.
Goldman Sachs Analyst forecast on IN:NEULANDLAB
Shyam SrinivasanGoldman Sachs
Goldman Sachs
₹14,700₹15,200
Buy
28.05%
Upside
Reiterated
04/18/25
Neuland Laboratories Ltd (NLL:IN) PT Raised to INR15,200 at Goldman SachsGoldman Sachs analyst Shyam Srinivasan raised the price target on Neuland Laboratories Ltd (NLL:IN) to INR15,200.00 (from INR14,700.00) while maintaining a Buy rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on IN:NEULANDLAB
TipRanks AITipRanks
Not Ranked
TipRanks
₹15,988
Hold
34.69%
Upside
Reiterated
07/15/25
Neuland Laboratories' overall stock score reflects strong financial performance and positive technical indicators, tempered by high valuation concerns. The company's robust revenue growth and solid balance sheet position it well for future growth, but the high P/E ratio and overbought technical signals suggest caution in valuation.
Goldman Sachs Analyst forecast on IN:NEULANDLAB
Shyam SrinivasanGoldman Sachs
Goldman Sachs
₹14,700₹15,200
Buy
28.05%
Upside
Reiterated
04/18/25
Neuland Laboratories Ltd (NLL:IN) PT Raised to INR15,200 at Goldman SachsGoldman Sachs analyst Shyam Srinivasan raised the price target on Neuland Laboratories Ltd (NLL:IN) to INR15,200.00 (from INR14,700.00) while maintaining a Buy rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Neuland Laboratories Ltd.

1 Month
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
-2.93%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of -2.93% per trade.
3 Months
xxx
Success Rate
1/3 ratings generated profit
33%
Average Return
-8.47%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -8.47% per trade.
1 Year
Shyam SrinivasanGoldman Sachs
Success Rate
3/4 ratings generated profit
33%
Average Return
+9.60%
reiterated a buy rating 5 days ago
Copying Shyam Srinivasan's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +9.60% per trade.
2 Years
xxx
Success Rate
1/3 ratings generated profit
33%
Average Return
-5.90%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -5.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NEULANDLAB Analyst Recommendation Trends

Rating
Jan 25
Mar 25
Apr 25
Strong Buy
0
0
0
Buy
1
2
3
Hold
0
0
0
Sell
0
0
0
Strong Sell
0
0
0
total
1
2
3
In the current month, NEULANDLAB has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NEULANDLAB average Analyst price target in the past 3 months is 15,200.00.
Each month's total comprises the sum of three months' worth of ratings.

NEULANDLAB Financial Forecast

NEULANDLAB Earnings Forecast

Next quarter’s earnings estimate for NEULANDLAB is ₹51.53 with a range of ₹51.53 to ₹51.53. The previous quarter’s EPS was ₹21.64. NEULANDLAB beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.07% of the time in the same period. In the last calendar year NEULANDLAB has Outperformed its overall industry.
Next quarter’s earnings estimate for NEULANDLAB is ₹51.53 with a range of ₹51.53 to ₹51.53. The previous quarter’s EPS was ₹21.64. NEULANDLAB beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.07% of the time in the same period. In the last calendar year NEULANDLAB has Outperformed its overall industry.

NEULANDLAB Sales Forecast

Next quarter’s sales forecast for NEULANDLAB is ₹3.61B with a range of ₹3.40B to ₹3.82B. The previous quarter’s sales results were ₹3.28B. NEULANDLAB beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.42% of the time in the same period. In the last calendar year NEULANDLAB has Outperformed its overall industry.
Next quarter’s sales forecast for NEULANDLAB is ₹3.61B with a range of ₹3.40B to ₹3.82B. The previous quarter’s sales results were ₹3.28B. NEULANDLAB beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.42% of the time in the same period. In the last calendar year NEULANDLAB has Outperformed its overall industry.

NEULANDLAB Stock Forecast FAQ

What is IN:NEULANDLAB’s average 12-month price target, according to analysts?
Based on analyst ratings, Neuland Laboratories Ltd.’s 12-month average price target is 15,200.00.
    What is IN:NEULANDLAB’s upside potential, based on the analysts’ average price target?
    Neuland Laboratories Ltd. has 28.05% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Neuland Laboratories Ltd. a Buy, Sell or Hold?
          Neuland Laboratories Ltd. has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Neuland Laboratories Ltd.’s share price target?
            The average share price target for Neuland Laboratories Ltd. is 15,200.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is ₹15,200.00 ,and the lowest forecast is ₹15,200.00. The average share price target represents 28.05% Increase from the current price of ₹11,870.35.
              What do analysts say about Neuland Laboratories Ltd.?
              Neuland Laboratories Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of Neuland Laboratories Ltd.?
                To buy shares of IN:NEULANDLAB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis